For any of us who have fought with insurance companies to allow for better access to intensive therapies for patients after a stroke, it seems inherent that “more is more” when it comes stroke rehab. A number of studies and review articles have shown evidence to this effect, and in their current article, authors Lohse and colleagues have made the case for a reliable dose-response relationship between the time scheduled for therapy and improvement on clinical measures of function and impairment.
More is more: Dose-response benefits of therapy after stroke
For any of us who have fought with insurance companies to allow for better access to intensive therapies for patients after a stroke, it seems inherent that “more is more” when it comes stroke rehab. A number of studies and review articles have shown evidence to this effect, and in their current article, authors Lohse and colleagues have made the case for a reliable dose-response relationship between the time scheduled for therapy and improvement on clinical measures of function and impairment.
And if you want less dead and damaged neurons you will figure out a way to stop the neuronal cascade of death as reported by Rockefeller University in 2009. Even though Dr. Michael Tymianski, of the Toronto Western Hospital Research Institute in Canada mentions that more than 1000 drugs aimed at preventing brain damage that have failed to work in people, even though they worked well in mice or rats. This is easily explainable because in 2013 H. Shaw Warren wrote about rodent inflammation is not the same as human inflammation. Putting everything together and solving the 5 problems in the cascade of death will prevent vast amounts of disability and I bet that would mean more than 10% get to full recovery.